Results 191 to 200 of about 276,101 (206)

Impact of a comprehensive geriatric assessment on decision-making in older patients with hematological malignancies

European Journal of Haematology, 2021
Martin Gauthier, Loic Ysebaert, Balardy Laurent   +2 more
exaly  

Oncolytic Virus Therapy with HSV-1 for Hematological Malignancies

Molecular Therapy, 2021
Osamu Imataki, Akifumi Takaori-Kondo, Toshio Kitawaki   +2 more
exaly  

The prognostic and therapeutic potentials of CTLA-4 in hematological malignancies

Expert Opinion on Therapeutic Targets, 2022
Mohammad Hojjat-Farsangi, Hamed Mohammadi, Jamshid G Navashenaq   +2 more
exaly  

miRNAs mediated drug resistance in hematological malignancies

Seminars in Cancer Biology, 2022
Hugo R Caires, M Helena Vasconcelos, Rui Bergantim   +2 more
exaly  

Old drugs, new uses: Drug repurposing in hematological malignancies

Seminars in Cancer Biology, 2021
Subash C Jonnalagadda, Kishore B Challagundla, Manoj Pandey   +2 more
exaly  

The role of NFAT in the pathogenesis and targeted therapy of hematological malignancies

European Journal of Pharmacology, 2022
Yangqiu Li, Chengwu Zeng, Yikai Zhang
exaly  

Copper levels in patients with hematological malignancies

European Journal of Internal Medicine, 2012
Georgia D Kaiafa, Michael D Diamantidis, Maria Chatzidimitriou   +2 more
exaly  

11q Deletions in Hematological Malignancies

Leukemia and Lymphoma, 2001
Sakari Knuutila, Outi Monni
exaly  

Physical performance, depression, immune status and fatigue in patients with hematological malignancies after treatment

Annals of Oncology, 2004
Dieter Böning, Stefan Schwartz, F Dimeo
exaly  

Novel epigenetic therapies in hematological malignancies: Current status and beyond

Seminars in Cancer Biology, 2018
Paolo Gallipoli
exaly